Intravenous Immunoglobulin (IVIg) Market Report

Global and China Intravenous Immunoglobulin (IVIg) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 30, 2022
  • PAGES：182
  • REPORT CODE：GMM1423383
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Intravenous immunoglobulin refers to the globulin which is specially prepared for intravenous infusion by precipitation and reprocessing of the components extracted from the plasma of healthy people by low-temperature ethanol method to remove the anti-complement activity and inactivate virus by Pasteurization.

    This report elaborates on the current development of the Intravenous Immunoglobulin (IVIg) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • ADMA Biologics, Inc

    • China Biologics Products, Inc

    • Grifols

    • Takeda Pharmaceuticals

    • Shanghai RAAS Blood Products Co Ltd

    • Hualan Biological Engineering Inc

    • LFB group

    • Octapharma

    • Baxter International Inc

    • CSL Behring

    • Kedrion Biopharma Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • IVIg Liquid

    • IVIg Powder

    Application:

    • Immunodeficiency

    • Autoimmune Disease

    • Acute Infection

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Intravenous Immunoglobulin (IVIg) Industry Overview

      • 1.1.1 Intravenous Immunoglobulin (IVIg) Market Scope and Market Segments

      • 1.1.2 Intravenous Immunoglobulin (IVIg) Industry Characteristics

      • 1.1.3 Global and China Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Intravenous Immunoglobulin (IVIg) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 IVIg Liquid

      • 1.2.2 IVIg Powder

    • 1.3 Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Immunodeficiency

      • 1.3.2 Autoimmune Disease

      • 1.3.3 Acute Infection

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Intravenous Immunoglobulin (IVIg) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Intravenous Immunoglobulin (IVIg) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Intravenous Immunoglobulin (IVIg) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Intravenous Immunoglobulin (IVIg) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Intravenous Immunoglobulin (IVIg) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Intravenous Immunoglobulin (IVIg) Industry PEST Analysis

    • 2.3 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Intravenous Immunoglobulin (IVIg) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Intravenous Immunoglobulin (IVIg) Industry

    Chapter 3 Global and China Intravenous Immunoglobulin (IVIg) Market, by Manufacturer

    • 3.1 Global and China Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Intravenous Immunoglobulin (IVIg) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Intravenous Immunoglobulin (IVIg) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Intravenous Immunoglobulin (IVIg) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Intravenous Immunoglobulin (IVIg) Market Top 3 Players

    Chapter 4 Global and China Intravenous Immunoglobulin (IVIg) Market, by Type (2017-2028)

    • 4.1 Intravenous Immunoglobulin (IVIg) Market Trend, by Type

    • 4.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Intravenous Immunoglobulin (IVIg) Price Trend, by Type (2017-2028)

    • 4.3 China Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Intravenous Immunoglobulin (IVIg) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Intravenous Immunoglobulin (IVIg) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Intravenous Immunoglobulin (IVIg) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Intravenous Immunoglobulin (IVIg) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Intravenous Immunoglobulin (IVIg) Market Analysis

    • 7.1 North America Intravenous Immunoglobulin (IVIg) Market, by Type

    • 7.2 North America Intravenous Immunoglobulin (IVIg) Market, by Application

    • 7.3 North America Intravenous Immunoglobulin (IVIg) Market Analysis and Forecast, by Country

      • 7.3.1 United States Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Intravenous Immunoglobulin (IVIg) Market Analysis

    • 8.1 Europe Intravenous Immunoglobulin (IVIg) Market, by Type

    • 8.2 Europe Intravenous Immunoglobulin (IVIg) Market, by Application

    • 8.3 Europe Intravenous Immunoglobulin (IVIg) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Intravenous Immunoglobulin (IVIg) Market Analysis

    • 9.1 APAC Intravenous Immunoglobulin (IVIg) Market, by Type

    • 9.2 APAC Intravenous Immunoglobulin (IVIg) Market, by Application

    • 9.3 APAC Intravenous Immunoglobulin (IVIg) Market Analysis and Forecast, by Country

      • 9.3.1 China Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Analysis

    • 10.1 Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Market, by Type

    • 10.2 Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Market, by Application

    • 10.3 Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Intravenous Immunoglobulin (IVIg) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Intravenous Immunoglobulin (IVIg) Company Profiles

      • 11.1 ADMA Biologics, Inc

        • 11.1.1 ADMA Biologics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 ADMA Biologics, Inc Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.1.3 ADMA Biologics, Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 China Biologics Products, Inc

        • 11.2.1 China Biologics Products, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 China Biologics Products, Inc Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.2.3 China Biologics Products, Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Grifols

        • 11.3.1 Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Grifols Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.3.3 Grifols Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Takeda Pharmaceuticals

        • 11.4.1 Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Takeda Pharmaceuticals Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.4.3 Takeda Pharmaceuticals Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Shanghai RAAS Blood Products Co Ltd

        • 11.5.1 Shanghai RAAS Blood Products Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Shanghai RAAS Blood Products Co Ltd Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.5.3 Shanghai RAAS Blood Products Co Ltd Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Hualan Biological Engineering Inc

        • 11.6.1 Hualan Biological Engineering Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Hualan Biological Engineering Inc Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.6.3 Hualan Biological Engineering Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 LFB group

        • 11.7.1 LFB group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 LFB group Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.7.3 LFB group Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Octapharma

        • 11.8.1 Octapharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.8.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Baxter International Inc

        • 11.9.1 Baxter International Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Baxter International Inc Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.9.3 Baxter International Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 CSL Behring

        • 11.10.1 CSL Behring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 CSL Behring Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.10.3 CSL Behring Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Kedrion Biopharma Inc

        • 11.11.1 Kedrion Biopharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Kedrion Biopharma Inc Intravenous Immunoglobulin (IVIg) Product Profiles, Application and Specification

        • 11.11.3 Kedrion Biopharma Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Intravenous Immunoglobulin (IVIg) Industry Investment Prospect and Risk Assessment

    • 12.1 Intravenous Immunoglobulin (IVIg) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Intravenous Immunoglobulin (IVIg) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Production Value and Growth Rate (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Production Value and Growth Rate (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Liquid (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Powder (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Immunodeficiency (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Autoimmune Disease (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Acute Infection (2017-2028)

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Intravenous Immunoglobulin (IVIg) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Intravenous Immunoglobulin (IVIg) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Intravenous Immunoglobulin (IVIg) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Intravenous Immunoglobulin (IVIg) Market Share, by Manufacturer in 2021

    • Figure Global and China Intravenous Immunoglobulin (IVIg) Market Share, by Manufacturer in 2022

    • Table Global Intravenous Immunoglobulin (IVIg) Sales Volume, by Type (2017-2028)

    • Table Global Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Table Global Intravenous Immunoglobulin (IVIg) Sales Value, by Type (2017-2028)

    • Table Global Intravenous Immunoglobulin (IVIg) Sales Value Share, by Type (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Price Trend, by Type (2017-2028)

    • Table China Intravenous Immunoglobulin (IVIg) Sales Volume, by Type (2017-2028)

    • Table China Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Table China Intravenous Immunoglobulin (IVIg) Sales Value, by Type (2017-2028)

    • Table China Intravenous Immunoglobulin (IVIg) Sales Value Share, by Type (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Price Trend, by Type (2017-2028)

    • Table Global Intravenous Immunoglobulin (IVIg) Sales Volume, by Application (2017-2028)

    • Table Global Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Table Global Intravenous Immunoglobulin (IVIg) Sales Value, by Application (2017-2028)

    • Table Global Intravenous Immunoglobulin (IVIg) Sales Value Share, by Application (2017-2028)

    • Figure Global Intravenous Immunoglobulin (IVIg) Sales Value Share, by Application (2017-2028)

    • Table China Intravenous Immunoglobulin (IVIg) Sales Volume, by Application (2017-2028)

    • Table China Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Table China Intravenous Immunoglobulin (IVIg) Sales Value, by Application (2017-2028)

    • Table China Intravenous Immunoglobulin (IVIg) Sales Value Share, by Application (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Sales Value Share, by Application (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export (2017-2022)

    • Table North America Intravenous Immunoglobulin (IVIg) Sales Volume, by Type (2017-2028)

    • Table North America Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Figure North America Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Table North America Intravenous Immunoglobulin (IVIg) Sales Volume, by Application (2017-2028)

    • Table North America Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure North America Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure United States Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Table Europe Intravenous Immunoglobulin (IVIg) Sales Volume, by Type (2017-2028)

    • Table Europe Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Table Europe Intravenous Immunoglobulin (IVIg) Sales Volume, by Application (2017-2028)

    • Table Europe Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure UK Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure France Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure France Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Table APAC Intravenous Immunoglobulin (IVIg) Sales Volume, by Type (2017-2028)

    • Table APAC Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Table APAC Intravenous Immunoglobulin (IVIg) Sales Volume, by Application (2017-2028)

    • Table APAC Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure China Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure India Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure India Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Intravenous Immunoglobulin (IVIg) Sales Value and Growth Rate (2017-2028)

    • Table ADMA Biologics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ADMA Biologics, Inc Product Profiles, Application and Specification

    • Table ADMA Biologics, Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table China Biologics Products, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table China Biologics Products, Inc Product Profiles, Application and Specification

    • Table China Biologics Products, Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Grifols Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Grifols Product Profiles, Application and Specification

    • Table Grifols Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceuticals Product Profiles, Application and Specification

    • Table Takeda Pharmaceuticals Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shanghai RAAS Blood Products Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shanghai RAAS Blood Products Co Ltd Product Profiles, Application and Specification

    • Table Shanghai RAAS Blood Products Co Ltd Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hualan Biological Engineering Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hualan Biological Engineering Inc Product Profiles, Application and Specification

    • Table Hualan Biological Engineering Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table LFB group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table LFB group Product Profiles, Application and Specification

    • Table LFB group Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Octapharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Octapharma Product Profiles, Application and Specification

    • Table Octapharma Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Baxter International Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Baxter International Inc Product Profiles, Application and Specification

    • Table Baxter International Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CSL Behring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Behring Product Profiles, Application and Specification

    • Table CSL Behring Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kedrion Biopharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kedrion Biopharma Inc Product Profiles, Application and Specification

    • Table Kedrion Biopharma Inc Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US